LivaNova has published 12-month data supporting its proximal hypoglossal nerve stimulation (pHGNS) system for sleep apnea.

Proximal hypoglossal nerve stimulation offers a clinically significant response for adults with obstructive sleep apnea.

In a recent trial, 60 percent of patients using the device had fewer breathing interruptions and less daytime fatigue. For ...

Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...

Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an old drug just might help people with the condition, recent trial data shows.

Experts say that if the new drug gets approved, it may lead to a big shift in how we treat the condition. By Caroline Hopkins Legaspi Tens of millions of people in the United States struggle with ...

The disease affects as many as 80 million in the U.S. alone. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval. In November 2016, ...

It’s estimated that at least 25 million American adults and 936 million adults between the ages of 30 and 69 worldwide may suffer from obstructive sleep apnea, with many more people undiagnosed. The ...

Losing 5–10% of your body weight can significantly reduce the severity of sleep apnea symptoms and, in some cases, eliminate the condition altogether. Weight loss, through a combination of diet and ...

According to Brian Kinard, DMD, M.D., an associate professor in the University of Alabama at Birmingham School of Dentistry, sleep apnea is diagnosed when an individual stops breathing throughout the ...

The sixth developer beta of iOS 18.1 is now available for all compatible iPhone models. Here's everything you need to know about the update and the features it introduces. The company's sixth and most ...